Bulletin
Investor Alert

New York Markets Open in:

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 29, 2023, 5:15 p.m.

/zigman2/quotes/216320743/composite

$

22.01

Change

-0.45 -2.00%

Volume

Volume 35,054

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Previous close

$ 22.07

$ 22.46

Change

+0.39 +1.77%

Day low

Day high

$22.34

$23.22

Open

52 week low

52 week high

$15.44

$35.60

Open

Alexis A. Borisy

Alexis A. Borisy is an entrepreneur and businessperson who founded 9 companies, including: Foundation Medicine, Inc., Blueprint Medicines Corp. and EQRx, Inc. and who has been at the head of 13 different companies. Presently, Mr. Borisy is Chairman at Relay Therapeutics, Inc. (which he founded in 2015), Chairman at Tango Therapeutics, Inc., Partner at Third Rock Ventures LLC and Executive Chairman of EQRx International, Inc. (which he founded in 2020). Alexis A. Borisy is also Co-Chairman for Museum of Science and on the board of 5 other companies.

He previously held the position of Chairman at National Venture Capital Association, Executive Chairman of EQRx, Inc. (he founded the company in 2019), Chairman of FORMA Therapeutics, Inc. (he founded the company in 2007), Independent Director at Foundation Medicine, Inc. (he founded the company in 2009), Executive Chairman of Warp Drive Bio, Inc., Director at Tango Therapeutics Sub, Inc. and President, Chief Executive Officer & Director at CombinatoRx, Inc. (he founded the company in 2000).

He received an undergraduate degree from The University of Chicago and a graduate degree from Harvard University.

Transactions

Date Shares Transaction Value
11/09/2023 2,091,672   Award at $0 per share. 0
06/08/2023 5,200   Award at $0 per share. 0
06/16/2022 5,200   Award at $0 per share. 0
06/22/2021 3,617   Award at $0 per share. 0
06/17/2020 1,808   Award at $0 per share. 0

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Mr. Daniel Simon
Chief Business Officer
Ms. Linnet Zia
VP-Strategy, Financial Planning & Analysis
Ms. Luan M. Wilfong
Chief Human Resources Officer
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Flavia Borellini
Independent Director
Dr. Sushil Patel
Independent Director
Dr. Lorence H. Kim
Independent Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.